DCI Research

Mentored-research training award boosts the next generation of Duke physician-scientists.

The Duke Department of Pathology/Duke Clinical Labs has established the Division of Artificial Intelligence and Computational Pathology.

Duke researchers are using a $200,000 grant from NC Biotech to “supercharge” vital medical information.

Duke University ranked eighth among the nation’s top medical schools and research institutions for funding from the NIH.

Research on immunotherapy in NSCLC by Scott Antonia, MD, PhD, selected by ASCO for inclusion in Clinical Cancer Advances 2020.

DCI researchers use the modified polio virus to spur natural immune attack against tumors in animal studies.

Dorothy Sipkins, MD, PhD, and P. Kelly Marcom, MD, are co-PIs on a Phase 1 clinical trial of a new drug for breast cancer patients whose disease has spread to the bone.

Lawrence A. David, PhD, and Anthony D. Sung, MD, named recipients of the Damon Runyon-Rachleff Innovation Award for project to personalize pre-biotic treatments for HCT patients.

This year's Annual Report spotlights the work of the new Duke Center for Brain and Spine Metastasis at DCI as well as a Duke-Durham stomach cancer prevention partnership.